Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM version II) among outpatient pharmacy consumers

被引:272
作者
Atkinson, MJ
Kumar, R
Cappelleri, JC
Hass, SL
机构
[1] Pfizer Inc, La Jolla Labs, Worldwide Outcomes Res, San Diego, CA 92121 USA
[2] Merck & Co Inc, Whitehouse Stn, NJ USA
[3] Pfizer Inc, Groton, CT 06340 USA
[4] Elan Pharmaceut Inc, San Diego, CA USA
关键词
compliance; medication adherence; patient reported outcomes; patient satisfaction; psychometric validation; structural equation model; treatment satisfaction;
D O I
10.1111/j.1524-4733.2005.00066.x
中图分类号
F [经济];
学科分类号
02 ;
摘要
Objectives: The objectives of this study were twofold: 1) to evaluate the construct validity of the Treatment Satisfaction Questionnaire for Medication (TSQM v. II) using structural equation modeling (SEM); and 2) to assess its concurrent validity using medication adherence criteria. Methods: Pharmacy patients filling a new medication prescription (n = 342) were recruited from 14 Michigan pharmacies to participate in a 4-week treatment satisfaction study. The TSQM v. II was tested for model fit against an established theoretical model (the Decisional Balance Model of Treatment Satisfaction) using hierarchical confirmatory factor analysis (HCFA). Regression and discriminant analytic models were used to examine the criterion-related validity of the measure. Results: An exploratory factor analysis, used for TSQM v. II item reduction, revealed a strongly dimensional instrument (Effectiveness, Side Effects, and Convenience) and explained 88% of total pooled variance. Results of an HCFA using the final TSQM v. II items suggested a good model fit with the data (P > 0.54). In support of concurrent validity, the TSQM scales explained between 9% and 20% of the variance in dosing adherence and 60% of the variance in the likelihood of future use. Discriminant analysis demonstrated the superior classification power of the hierarchical model of treatment satisfaction over the discrete attribute model when predicting medication discontinuation. Conclusions: The TSQM v. II has equivalent measurement characteristics as the TSQM v. I, yet uses four fewer items and more consistent wording. The value of the Decisional Balance Model for estimation of dosing adherence and medication persistence over time is discussed.
引用
收藏
页码:S9 / S24
页数:16
相关论文
共 28 条
[1]  
Aharony L, 1993, Med Care Rev, V50, P49, DOI 10.1177/002570879305000104
[2]   ATTITUDES AND NORMATIVE BELIEFS AS FACTORS INFLUENCING BEHAVIORAL INTENTIONS [J].
AJZEN, I ;
FISHBEIN, M .
JOURNAL OF PERSONALITY AND SOCIAL PSYCHOLOGY, 1972, 21 (01) :1-&
[3]   Comorbidity of late life depression: An opportunity for research on mechanisms and treatment [J].
Alexopoulos, GS ;
Buckwalter, K ;
Olin, J ;
Martinez, R ;
Wainscott, C ;
Krishnan, KRR .
BIOLOGICAL PSYCHIATRY, 2002, 52 (06) :543-558
[4]   Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease [J].
Atkinson M.J. ;
Sinha A. ;
Hass S.L. ;
Colman S.S. ;
Kumar R.N. ;
Brod M. ;
Rowland C.R. .
Health and Quality of Life Outcomes, 2 (1)
[5]  
ATKINSON MJ, 2004, NEW MEASURE PATIENT, P1
[6]   Evaluation of the consumer model: relationship between patients' expectations, perceptions and satisfaction with care [J].
Baron-Epel, O ;
Dushenat, M ;
Friedman, N .
INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE, 2001, 13 (04) :317-323
[7]   THRESHOLD MODEL OF ATTRIBUTE SATISFACTION DECISIONS [J].
BETTMAN, JR .
JOURNAL OF CONSUMER RESEARCH, 1974, 1 (02) :30-35
[8]   Management of the adverse effects of antiretroviral therapy and medication adherence [J].
Blake, M ;
Sherer, R .
CLINICAL INFECTIOUS DISEASES, 2000, 30 :S96-S116
[9]  
Boissel JP, 1996, THERAPIE, V51, P667
[10]  
Bowling A, 2001, QUAL HLTH CARE S1, V10, pi2, DOI DOI 10.1136/QHC.0100002